Phase I and pharmacokinetic study of the novel oral cell-cycle inhibitor Ro 31-7453 in patients with advanced solid tumors.
Dupont J, Bienvenu B, Aghajanian C, Pezzulli S, Sabbatini P, Vongphrachanh P, Chang C, Perkell C, Ng K, Passe S, Breimer L, Zhi J, DeMario M, Spriggs D, Soignet SL.
Dupont J, et al. Among authors: spriggs d.
J Clin Oncol. 2004 Aug 15;22(16):3366-74. doi: 10.1200/JCO.2004.12.007.
J Clin Oncol. 2004.
PMID: 15310782
Clinical Trial.